Clinical trials
Terminated Phase 1/2 Kidney Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Aravive, Inc. | 1 |
| City of Hope Medical Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| NiKang Therapeutics, Inc. | 1 |
| Rexahn Pharmaceuticals, Inc. | 1 |
| Roberto Pili | 1 |
| Sumitomo Pharma America, Inc. | 1 |
| Takeda | 1 |
| University of Kansas Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 14 |
| Carcinoma, Renal Cell | 8 |
| Neoplasm Metastasis | 4 |
| Melanoma | 3 |
| Breast Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Liver Neoplasms | 2 |
| Mesothelioma | 2 |
| Ovarian Neoplasms | 2 |
| Sarcoma | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.